Chronic cough, a condition characterized by a persistent cough lasting more than eight weeks, is an enigma that often challenges clinicians. Despite its prevalence, the diagnosis and management of this condition remain complex due to its multifactorial etiology and the variability in patient responses to treatment. This article aims to provide a comprehensive approach to diagnosing and managing chronic cough in clinical practice.
A systematic approach to diagnosis is paramount. A detailed history and physical examination can provide valuable clues. The clinician should consider factors such as the duration and severity of cough, associated symptoms, exposure history, and response to previous treatments. Diagnostic tests, including imaging studies, pulmonary function tests, and bronchoscopy, can further aid in identifying the underlying cause.
Management strategies should be tailored based on the underlying cause. Empirical treatment trials for common causes such as GERD, asthma, and upper airway cough syndrome can be beneficial. For refractory cases, a multidisciplinary approach involving pulmonologists, allergists, gastroenterologists, and speech therapists may be required.
Novel therapies are emerging in the field of chronic cough management. Neuromodulators like gabapentin and pregabalin have shown promise. Research is also underway to explore the role of specific P2X3 receptor antagonists. However, the long-term safety and efficacy of these treatments need further investigation.
Chronic cough is a complex condition that requires a comprehensive and systematic approach for effective diagnosis and management. While empirical treatments remain the mainstay, the role of novel therapies is emerging. Continued research and a multidisciplinary approach are vital to enhance our understanding and management of this perplexing condition.
1.
Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap
2.
Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal
3.
Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study
4.
The amount of liver tissue removed during gallbladder surgery has no discernible impact on overall survival.
5.
Long-Acting Interferon Therapy Approved for ET
1.
Molecular Network Mapping in Hematologic Disease
2.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
3.
Hematopoietic Stem Cell Clonal Dynamics Across the Lifespan
4.
Connected Hematology Laboratory Networks for Automated Cross-Institution Data Exchange
5.
Digital Oncology Ecosystems Integrating Longitudinal Patient Trajectories: Transforming Cancer Care through Data-Driven Innovation
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Common side effects of cancer treatment and how they are managed
3.
Clinical Excellence in Hematology
4.
Best Practices in Hematology
5.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation